Liquid biopsy diagnostics for non-small cell lung cancer via elucidation of tRNA signatures
Abstract Background Lung cancer, particularly non-small cell lung cancer (NSCLC), accounts for about 85% of all lung cancer cases and remains a major global health challenge. Traditional diagnostic methods, such as chest X-rays and low-dose CT scans, have limitations, including high false-positive r...
Saved in:
| Main Authors: | Zhuokun Feng, Masaki Nasu, Gehan Devendra, Ayman A. Abdul-Ghani, Owen T. M. Chan, Jeffrey A. Borgia, Zitong Gao, Hanqiu Zhang, Yu Chen, Ting Gong, Gang Luo, Hua Yang, Lang Wu, Yuanyuan Fu, Youping Deng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | Communications Medicine |
| Online Access: | https://doi.org/10.1038/s43856-025-01068-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A robust machine learning model based on ribosomal‐subunit‐derived piRNAs for diagnostic potential of nonsmall cell lung cancer across multicentre, large‐scale of sequencing data
by: Zitong Gao, et al.
Published: (2025-08-01) -
Liquid biopsies in cancer
by: Hang Yin, et al.
Published: (2025-03-01) -
Mammalian tRNA acetylation determines translation efficiency and tRNA quality control
by: Na Liu, et al.
Published: (2025-07-01) -
Liquid biopsy when MEAT is not the treat
by: K Govind Babu
Published: (2019-01-01) -
Fostering the implementation of liquid biopsy in clinical practice: meeting report 2024 of the European Liquid Biopsy Society (ELBS)
by: Klaus Pantel, et al.
Published: (2025-05-01)